L-Glutamic γ-monohydroxamate is an antitumor compound that impedes cell proliferation and selectively hinders L-histidine uptake in microvascular endothelial cells. Additionally, this compound serves as a vanadium ligand, enhancing glucose uptake and metabolism, leading to reduced blood glucose levels in vivo [1] [2] [3].